Showing results (81-90 of 106) with videos related to

Sort By:
Pageof 11
The Lancet Regional Health. Southeast Asia|May 17, 2024
AI-based pipeline for early screening of lung cancer: integrating radiology, clinical, and genomics dataUllas Batra, Shrinidhi Nathany, Swarsat Kaushik Nath, et al.
The Breast Journal|September 1, 2020
Impact of 2018 ASCO/CAP guidelines on HER-2 reporting categories of IHC and reflex FISH in breast cancerSunil Pasricha, Vidya Menon, Gurudutt Gupta, et al.
Lung India : Official Organ of Indian Chest Society|September 1, 2018
The detection of primary and secondary EGFR mutations using droplet digital PCR in patients with nonsmall cell lung cancerMoushumi Suryavanshi, Anurag Mehta, Manoj Kumar Panigrahi, et al.
Indian Journal of Nuclear Medicine : IJNM : the Official Journal of the Society of Nuclear Medicine, India|May 1, 2020
Role of <sup>18</sup>F-Flurodeoxyglucose Positron-Emission Tomography/Computed Tomography in the Evaluation of Early Response to Neoadjuvant Chemotherapy in Patients with Locally Advanced Triple-Negative Breast CancerBina Basnet, Pankaj Goyal, Vivek Mahawar, et al.
Japanese Journal of Clinical Oncology|February 13, 2019
Ki-67 labeling index as a predictor of response to neoadjuvant chemotherapy in breast cancerParveen Jain, Dinesh Chandra Doval, Ullas Batra, et al.
Indian Journal of Cancer|March 28, 2022
CONCORDANCE: A real-world evidence study to evaluate the concordance of detecting epidermal growth factor receptor (EGFR) mutation by circulating tumor DNA* versus tissue biopsy in patients with metastatic non-small cell lung cancerKumar Prabhash, Bivas Biswas, Sachin Khurana, et al.
Scientific Reports|April 5, 2020
A multi-institutional real world data study from India of 3453 non-metastatic breast cancer patients undergoing upfront surgeryDinesh Chandra Doval, Selvi Radhakrishna, Rupal Tripathi, et al.
Cancer Research and Treatment|March 28, 2022
Efficacy and Safety of Ceritinib 450 mg/day with Food and 750 mg/day in Fasted State in Treatment-Naïve Patients with ALK+ Non-Small Cell Lung Cancer: Results from the ASCEND-8 Asian Subgroup AnalysisByoung Chul Cho, Dong-Wan Kim, Ullas Batra, et al.
Current Problems in Cancer|April 3, 2020
Real world experience of treatment and outcome in ALK-rearranged metastatic nonsmall cell lung cancer: A multicenter study from IndiaAmol Patel, Ullas Batra, Kuruswamy Thurai Prasad, et al.
The British Journal of Radiology|December 21, 2022
Tri-modality therapy in advanced esophageal carcinoma: long-term results and insights from a developing world, institutional cohortKundan Singh Chufal, Irfan Ahmad, Ram Bajpai, et al.
Pageof 11